Total planned funding: $476,268,902
Clear active filters
FHI 360
NGO
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
South Africa | $71,595,345 |
Asia Regional Program | $60,346,961 |
Mozambique | $59,045,858 |
Zambia | $42,642,048 |
Zimbabwe | $38,523,311 |
Tanzania | $34,233,899 |
West Africa Region | $31,609,898 |
Nigeria | $20,346,960 |
Burundi | $16,296,667 |
Dominican Republic | $13,150,629 |
Vietnam | $10,332,979 |
Botswana | $9,730,917 |
Malawi | $9,354,859 |
Ethiopia | $8,480,898 |
Democratic Republic of the Congo | $6,722,325 |
enumerations.Philippines | $6,641,584 |
Lesotho | $5,031,189 |
Cambodia | $4,700,000 |
Côte d'Ivoire | $4,525,713 |
Eswatini | $4,232,255 |
Kenya | $4,189,197 |
South Sudan | $3,430,000 |
Indonesia | $3,380,435 |
Rwanda | $2,495,000 |
Ghana | $1,290,000 |
India | $1,000,000 |
China | $850,000 |
Haiti | $827,217 |
Western Hemisphere Region | $709,018 |
Uganda | $353,740 |
Thailand | $200,000 |
Organizational Types
NGO | $476,268,902 |
Program Areas
Prevention | $137,509,609 |
Treatment | $128,840,359 |
Care | $108,333,905 |
Testing | $64,989,259 |
Governance and Systems | $36,433,476 |
Management and Operations | $162,294 |
Budget Codes
HTXS: Treatment: Adult Treatment | $115,308,125 |
HVOP: Sexual Prevention: Other Sexual Prevention | $81,387,283 |
HKID: Care: Orphans and Vulnerable Children | $65,681,644 |
HVCT: Testing: HIV Testing and Counseling | $64,989,259 |
HBHC: Care: Adult Care and Support | $29,546,199 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $25,495,183 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $17,134,637 |
OHSS: Health Systems Strengthening | $15,653,207 |
HVSI: Strategic Information | $14,057,822 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $10,915,851 |
PDTX: Treatment: Pediatric Treatment | $8,450,120 |
HVTB: Care: TB/HIV | $6,776,397 |
HLAB: Laboratory Infrastructure | $6,722,447 |
PDCS: Care: Pediatric Care and Support | $6,329,665 |
HTXD: Treatment: ARV Drugs | $5,082,114 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $2,481,655 |
HVMS: Management and Operations | $162,294 |
HMIN: Biomedical Prevention: Injection Safety | $95,000 |
Top Partner Programs
FHI 360:
$476,268,902
View countries